Skip to main content
Clinical Trials/DRKS00027410
DRKS00027410
Completed
Not Applicable

Optimising polypharmacotherapy in geriatric patients with the medication review software Medinspector - OPtiMed

Viandar GmbH0 sites148 target enrollmentDecember 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polypharmacy in elderly patientsAppropriateness of medicationMedication therapy safety
Sponsor
Viandar GmbH
Enrollment
148
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2021
End Date
May 19, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Viandar GmbH

Eligibility Criteria

Inclusion Criteria

  • age \= 65 years
  • \- permanent intake of \= 5 active pharmaceutical substances with systemic effects (combinations of active ingredients in phytotherapeutics and homeopathics are counted as a single active substance)
  • \- written informed consent
  • \- completed software\-assisted medication review

Exclusion Criteria

  • \- For patients with more than one completed medication review in the recruitment period, only the first analysis will be considered.
  • \- The inclusion of patients per pharmacy is limited to a maximum of 15% of the calculated samplze size (n \= 148\), which corresponds to 22 patients per pharmacy.

Outcomes

Primary Outcomes

Not specified

Similar Trials